(Q40099782)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17668204%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

title

Lung carcinomas do not induce T-cell apoptosis via the Fas/Fas ligand pathway but down-regulate CD3 epsilon expression (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17668204%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

author

Heriberto Prado-García

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17668204%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

author name string

Dolores Aguilar-Cazares

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17668204%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Manuel Meneses-Flores

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17668204%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Jorge Morales-Fuentes

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17668204%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Jose Sullivan Lopez-Gonzalez

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17668204%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

publication date

1 August 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17668204%20AND%20SRC:MED&resulttype=core&format=json

Cancer Immunology, Immunotherapy

2 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17668204%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

volume

57

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17668204%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17668204%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

page(s)

325-336

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17668204%20AND%20SRC:MED&resulttype=core&format=json

Effect of human papillomavirus vaccines on vulvar, vaginal, and anal intraepithelial lesions and vulvar cancer.

2 January 2020

cites work

1 reference

https://api.crossref.org/works/10.2217%2F14750708.5.3.325

Trends in the incidence of invasive and in situ vulvar carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.5.3.325

In situ and invasive vulvar cancer incidence trends (1973 to 1987)

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.5.3.325

Epidemiology, diagnosis and treatment of vulvar intraepithelial neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.5.3.325

Integration of HPV-16 and HPV-18 DNA in vulvar intraepithelial neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.5.3.325

Human papillomavirus in squamous cell carcinoma of the vulva by polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.5.3.325

Natural history of vaginal intraepithelial neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.5.3.325

Vulvar intraepithelial neoplasia: aspects of the natural history and outcome in 405 women

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.5.3.325

Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.5.3.325

Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.5.3.325

Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.5.3.325

Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.5.3.325

Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.5.3.325

Preliminary results of 5% imiquimod cream in the primary treatment of vulva intraepithelial neoplasia grade 2/3.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.5.3.325

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.5.3.325

High-risk human papillomavirus infection of the genital tract of women with a previous history or current high-grade vulvar intraepithelial neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.5.3.325

21 January 2018

Identifiers

DOI

10.2217/14750708.5.3.325

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17668204%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

1 reference